UK Laboratory Dispatch:
UK Legal Matrix
PeptidesUK.org
British Clinical Chemical Registry
UK Academic MonographNeuropeptides & CNS SignalingIn Vitro Laboratory Only

Semax

Heptapeptide ACTH(4-10) Analog (Met-Glu-His-Phe-Pro-Gly-Pro)

PubChem Molecular SpecsValidated
CAS Registry:80714-61-0
Chemical Formula:C37H51N9O10S
Monoisotopic MW:813.92 g/mol
PubChem CID:122178
Primary Amino Acid Sequence (7 residues)
N-terminus → C-terminus
1Met
2Glu
3His
4Phe
5Pro
6Gly
7Pro

Pre-Clinical Overview

Semax is a synthetic regulatory heptapeptide structurally derived from an adrenocorticotropic hormone fragment (ACTH 4-10) stabilized with a C-terminal Pro-Gly-Pro tripeptide. Examined in neuropharmacology laboratories for its modulation of BDNF, trkB receptors, and cerebral monoamines.

Independent Laboratory Audit

Verified UK Suppliers for Semax

5 Audited British & European Sources
SupplierAssay PurityReagent FormatDispatch LocationNotesAccess
PharmaGrade Store≥99.1% (HPLC)sprayUnited Kingdom (Royal Mail 24)High-purity lyophilized vials and calibrated laboratory nasal atomizers.
Direct Peptides≥99.0% (HPLC)vialUK Hub & EuropeStandardized research vials verified across dual-wavelength UV chromatograms.
Direct Sarms≥98.6% (HPLC)sprayUnited Kingdom ExpressLaboratory liquid and powder reagent formats with analytical COA documentation.
Peptide Works≥98.9% (HPLC)vialManchester UK HubSolid-phase peptide synthesized vials dispatched with digital purity certificate.
PharmaLab Global≥99.3% (HPLC)sprayLondon UK HubHigh-throughput assayed vials and metered laboratory nasal spray units.
Biochemical Mechanisms of Action

Molecular Signaling Pathways

  • 1Upregulates brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) mRNA transcription in hippocampal neurons.
  • 2Enhances tyrosine kinase receptor B (trkB) phosphorylation, facilitating synaptic plasticity and dendritic arborization.
  • 3Modulates dopamine and serotonin metabolic turnover in prefrontal cortical tissue slices.
  • 4Provides neuroprotective ischemic mitigation by suppressing inducible nitric oxide synthase and caspase-3 cascades.
Pre-Clinical Laboratory Handling

Laboratory Evaluation Guidelines

Available as lyophilized powder or metered intranasal aqueous formulation. Demonstrates high enzymatic stability against carboxypeptidases owing to the C-terminal Pro-Gly-Pro motif.

Aseptic Dissolution & StorageUK Lab Standard
Recommended Diluent:Sterile Deionized Water USP or Saline Reagent Grade
Lyophilized Storage:-20°C dark vacuum desiccator (stable 24 months)
Reconstituted Storage:2°C to 8°C refrigerated; protect from light (stable 30 days)
Solution Stability:Enzymatically stable peptide; avoid repeated freezing and thawing cycles
Academic Biochemical Monograph

Receptor Affinity, SPPS Synthesis & Pharmacokinetics

Standardized chemical parameters, solid-phase synthesis criteria, and quantitative receptor affinity benchmarks for Semax.

Target ReceptorsBinding Kinetics
Primary Receptor Cascade
TrkB Receptor Activation via Endogenous BDNF Induction
Binding Affinity (Kd / Ki)
Functional induction: 3-fold elevation in TrkB/BDNF mRNA within 3h
Receptor Family
Neurotrophic Receptor Kinase & Melanocortin Modulator
Downstream Effectors
  • BDNF/TrkB axis transcriptional upregulation
  • Pyramidal neuron CA1 preservation under ischemic occlusion
  • Attenuation of lipid peroxidation and superoxide radical damage
SPPS MethodologyISO Criteria
Synthesis Protocol
Fmoc Solid-Phase Peptide Synthesis (SPPS)
N-Terminal / C-Terminal Mod
Free amine (H-Met-) · Free carboxylic acid (-Pro-OH)
Acid Cleavage Cocktail
TFA / TIS / H2O (95:2.5:2.5 vol/vol)
HPLC Retention Standard
RP-C18: 9.6 min (0.1% TFA / ACN gradient)
PharmacokineticsIn Vitro / In Vivo
Elimination Half-Life
t1/2 ≈ 20 - 24 hours (stabilized by C-terminal Pro-Gly-Pro motif)
Primary Degradation Pathway
Resistant to neutral endopeptidases; slow aminopeptidase hydrolysis
Bioavailability Profile
Neurobiology assay benchmark
Renal Filtration Threshold
Rapid glomerular excretion (MW: 813.92 Da)
Quantitative Pre-Clinical & Clinical Evidence Matrix

Documented Biochemical Endpoints & Statistical Significance

Study DesignCohort (n)Measured Biological EndpointStatistical SignificanceNCBI Citation
In Vitro Assayn = 30 glial and neuronal culturesQuantification of BDNF and trkB mRNA expressionp < 0.001 vs baselinePMID 16787421
Preclinical In Vivon = 48 carotid occlusion rodent modelsPreservation of CA1 hippocampal pyramidal neuron densityp < 0.01 vs ischemia groupPMID 9444747
Peer-Reviewed Academic Citations

Indexed Scientific Literature

Semax, an ACTH(4-10) analogue with nootropic properties, stimulates BDNF expression in the rat hippocampus
Neuroscience Letters (2006) · Dolotov OV, Eremin KO, Andreeva LA, et al.
Key Finding: Reported rapid multi-fold induction of hippocampal BDNF mRNA and protein expression within 3 hours.
BIOCHEMICAL & REGULATORY Q&A

Curated Scientific Q&A for Semax

Authoritative pre-clinical, analytical, and statutory handling guidelines for laboratory researchers.

5 Curated Questions

Semax (Heptapeptide ACTH(4-10) Analog (Met-Glu-His-Phe-Pro-Gly-Pro)) is indexed in the CAS Registry under #80714-61-0. Its empirical molecular formula is C37H51N9O10S with a monoisotopic molecular weight of 813.92 g/mol. It is cataloged under the Neuropeptides & CNS Signaling research classification.

Citation Benchmark: PubChem CID 122178; British Pharmacopoeia Appendix III
Biological Pathway Correlates

More Reagents in Neuropeptides & CNS Signaling

View Pathway Hub
Human Trial DataCAS 129954-34-3

Selank

Synthetic Tuftsin Heptapeptide Analogue (Thr-Lys-Pro-Arg-Pro-Gly-Pro)

C33H57N11O9751.88 g/molNeuropeptides & CNS Signaling

Selank is a synthetic regulatory heptapeptide derived from the immunomodulatory tetrapeptide tuftsin, extended with a C-terminal Pro-Gly-Pro tripeptide. Examined in neuroimmunology laboratories for its allosteric modulation of GABAA receptors, enkephalinase inhibition, and IL-6 expression.

Verified UK Sourcing Partners:
PharmaGrade Store (≥99.2% (HPLC))Direct Peptides (≥99.0% (HPLC))Direct Sarms (≥98.6% (HPLC))Peptide Works (≥98.9% (HPLC))PharmaLab Global (≥99.3% (HPLC))
View Full Technical Monograph